varenicline has been researched along with Autosomal Dominant Striatonigral Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Greenstein, PE; Jahan, I; Miller, A; Perlman, SL; Sullivan, KL; Wecker, L; Zesiewicz, TA | 1 |
1 trial(s) available for varenicline and Autosomal Dominant Striatonigral Degeneration
| Article | Year |
|---|---|
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
Topics: Adult; Affect; Aged; Benzazepines; Double-Blind Method; Female; Gait; Humans; Machado-Joseph Disease; Male; Middle Aged; Motor Activity; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Varenicline | 2012 |